Table 3.
Non-metastatic | Metastatic | Odds ratio | p-value | |
---|---|---|---|---|
Sex | 0.8 | 1.0 | ||
Male | 9 | 3 | ||
Female | 15 | 4 | ||
Age | 12 | 0.028 | ||
≤40 years | 16 | 1 | ||
>40 years | 8 | 6 | ||
Tumour site | 3.7 | 0.30 | ||
One lobe | 20 | 4 | ||
Two lobes | 4 | 3 | ||
Tumour focality | 1.1 | 1.0 | ||
Unifocal | 13 | 4 | ||
Multifocal | 9 | 3 | ||
Extrathyroid extension | 2 | 1.0 | ||
Absent | 8 | 2 | ||
Present | 2 | 1 | ||
Side of positive nodes | 26 | 0.014 | ||
Ipsilateral | 13 | 2 | ||
Contra/bilateral | 1 | 4 | ||
Site of positive nodes | 1.1 | 1.0 | ||
Lateral | 5 | 2 | ||
Lateral and central | 9 | 4 | ||
T stage | – | 0.18 | ||
1 | 3 | 3 | ||
2 | 8 | 2 | ||
3 | 9 | 1 | ||
N stage | 4.2 | 0.37 | ||
0 | 10 | 1 | ||
1 | 14 | 6 | ||
Median number of positive nodes | 3 | 12 | – | 0.14 |
Median lymph node ratio | 0.15 | 0.58 | – | 0.17 |
Adjuvant chemotherapy | 35 | 0.004 | ||
No | 14 | 1 | ||
Yes | 2 | 5 | ||
Adjuvant radiotherapy | 0.9 | 1.0 | ||
No | 9 | 3 | ||
Yes | 7 | 2 |